Table 2 Studies applying hypothermia to patients with symptomatic vasospasm refractory to conventional treatment
Study | Number of patients (n) | Target temperature (°C) | Duration of hypothermia (days) | Favorable outcome*, % (n) | Mortality rate, % (n) |
|---|---|---|---|---|---|
Nagao and colleagues (2000) | 5 | 32 to 34 | 5 to 14 | 80.0% (4) | 0.0% (0) |
Nakamura and colleagues (2002) | 5 | 32 to 34 | 5 to 14 | 40.0% (2) | 60.0% (3) |
Nagao and colleagues (2003) | 8 | 32 to 34 | 5 to 12 | 87.5% (7) | 0.0% (0) |
Seule and colleagues (2009) | 28 | 33 to 34 | 1 to 16 | 57.1% (16) | 28.6% (8) |
Total | 46 | Â | Â | 63.0% (29) | 26.1% (12) |